Zonisamide Capsule
Product Images NDC 76282-228

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 76282-228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mg (100mgcapsule)

Label for Zonisamide Capsules USP 100 mg, an oral prescription drug. The label shows the product name, strength, quantity of 100 capsules, and the labeler Exelan Pharmaceuticals, Inc. It includes storage instructions, a note to pharmacists to dispense a medication guide, and manufacturing details. A barcode and QR code are also visible.*

FDA Label Image

25mgcapsule

Label for Zonisamide Capsules USP 25 mg oral capsules. The label shows the product name, strength (25 mg), and dosage form (capsule), with a package count of 100 capsules. It includes manufacturer information for Exelan Pharmaceuticals, Inc., and storage instructions to keep the capsules at 20° to 25°C in a dry place protected from light. The label also contains the NDC number and a barcode.*

FDA Label Image

50mgcapsule

Label for Zonisamide Capsules USP 50 mg oral capsules, containing 100 capsules per bottle. The label includes the NDC 76282-227-01 and states the product is prescription only (Rx Only). It is manufactured for Exelan Pharmaceuticals, Inc., with additional manufacturer information for Invagen Pharmaceuticals, Inc. Storage and usage instructions are also provided on the label.*

FDA Label Image

Fig1 (Figure1)

A cumulative distribution plot comparing the percentage reduction in all partial seizures rate between treatment arms of Zonisamide and Placebo. The x-axis represents the percentage of patients, and the y-axis represents the percentage change in seizure rate from worsening to improvement, with a baseline of no change.*

FDA Label Image

Structure (Structure)

Chemical structure of Zonisamide, showing a benzisoxazole ring attached to a methanesulfonamide group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.